Loading…
Data as of .
| Company | Industry | Market cap | 1M | 6M | Revenue growth | Op. margin | Fwd P/E |
|---|---|---|---|---|---|---|---|
| Samsung Biologics 207940.KS | Biotechnology | $53.7B | +19% | +3% | -20% | 43% | 38.7× |
| Celltrion 068270.KS | Biotechnology | $34.3B | +15% | +10% | +40% | 32% | 34.1× |
| ALTEOGEN 196170.KS | Biotechnology | $10.3B | -22% | -46% | +61% | 53% | 47.0× |
| Samsung Epis 0126Z0.KS | Pharmaceuticals: Major | $6.39B | -5% | -36% | n/a | -25% | 24.0× |
| SKBP 326030.KS | Pharmaceuticals: Major | $5.12B | +17% | -11% | +39% | 35% | 21.6× |
| HanmiPharm 128940.KS | Pharmaceuticals: Major | $4.36B | -13% | +2% | +14% | 16% | 16.8× |
| Yuhan 000100.KS | Pharmaceuticals: Major | $4.05B | +7% | -12% | +5% | 5% | 38.6× |
| HLB 028300.KS | Biotechnology | $3.06B | -32% | -49% | +29% | -96% | n/a |
| Sam Chun Dang Pharm 000250.KS | Pharmaceuticals: Major | $2.91B | -29% | -59% | +21% | 7% | n/a |
| Hanmi Science 008930.KS | Medical Distributors | $2.71B | -7% | +44% | +6% | 5% | n/a |
| SKBS 302440.KS | Biotechnology | $2.22B | +1% | -11% | +23% | -25% | n/a |
| PharmaResearch 214450.KS | Pharmaceuticals: Major | $1.79B | -24% | -25% | +34% | 39% | 12.4× |
| Peptron 087010.KS | Biotechnology | $1.67B | -26% | -63% | +16% | -427% | n/a |
| LigaChem Biosciences 141080.KS | Pharmaceuticals: Major | $1.59B | -27% | -68% | -33% | -208% | n/a |
| Hugel 145020.KS | Biotechnology | $1.52B | +2% | -26% | +17% | 38% | 15.7× |
| ABL Bio 298380.KS | Pharmaceuticals: Major | $1.49B | -29% | -73% | -64% | -251% | n/a |
| Mezzion Pharma 140410.KS | Pharmaceuticals: Major | $1.42B | -7% | -29% | +7% | -223% | n/a |
| Hanall Biopharma 009420.KS | Pharmaceuticals: Major | $1.34B | -22% | -25% | +5% | 3% | n/a |
| Voronoi 310210.KS | Pharmaceuticals: Major | $1.31B | -35% | -66% | +24% | -1,947% | n/a |
| D&D Pharmatech 347850.KS | Pharmaceuticals: Major | $1.28B | -18% | -49% | -71% | -1,368% | n/a |
| Celltrion Pharm 068760.KS | Pharmaceuticals: Major | $1.27B | -1% | -29% | +14% | 11% | n/a |
| OliX Pharmaceuticals 226950.KS | Pharmaceuticals: Major | $1.26B | -39% | -57% | +81% | -305% | n/a |
| CLASSYS 214150.KS | Medical Specialties | $1.25B | -16% | -54% | +25% | 46% | 12.1× |
| GC Biopharma 006280.KS | Pharmaceuticals: Major | $1.18B | +7% | +2% | -3% | 4% | 5.0× |
| ST Pharm 237690.KS | Pharmaceuticals: Major | $1.12B | -25% | -52% | +26% | 18% | 27.9× |
| L&C BIO 290650.KS | Medical Specialties | $1.07B | +29% | -17% | +53% | 17% | 213.2× |
| Oscotec 039200.KS | Pharmaceuticals: Major | $1.02B | -9% | -30% | +233% | 62% | 56.8× |
| Seegene 096530.KS | Medical Specialties | $915M | -20% | +26% | +12% | 13% | 15.9× |
| Daewoong Pharm 069620.KS | Pharmaceuticals: Major | $874M | -7% | -30% | +9% | 12% | 5.8× |
| SK Discovery 006120.KS | Pharmaceuticals: Major | $804M | -13% | +11% | +20% | 3% | n/a |
| DongKook Pharmaceutical 086450.KS | Pharmaceuticals: Major | $776M | +4% | -1% | +13% | 10% | 12.4× |
| HK inno.N 195940.KS | Medical/Nursing Services | $745M | -12% | -32% | +7% | 12% | 11.8× |
| Livsmed 491000.KS | Medical Specialties | $706M | -1% | -47% | +89% | -59% | n/a |
| Chongkundang 185750.KS | Pharmaceuticals: Major | $611M | -5% | -26% | +7% | 4% | 12.6× |
| SD Biosensor 137310.KS | Electronic Equipment/Instruments | $573M | -4% | -22% | +5% | -9% | n/a |
| Boryung 003850.KS | Pharmaceuticals: Major | $531M | -3% | -14% | +6% | 6% | 11.1× |
| Qurient 115180.KS | Biotechnology | $503M | -37% | -59% | -20% | -517% | n/a |
| Daewoong 003090.KS | Pharmaceuticals: Major | $485M | +3% | -29% | +5% | 11% | 4.1× |
| JS Link 127120.KS | Medical/Nursing Services | $481M | -37% | -57% | +51% | -76% | n/a |
| Komipharm International 041960.KS | Biotechnology | $460M | -22% | -12% | -3% | 2% | n/a |
| Myung in Pharm 317450.KS | Pharmaceuticals: Other | $455M | -2% | -24% | +7% | 35% | n/a |
| PROTEINA 468530.KS | Medical Specialties | $450M | +25% | -2% | -59% | -1,178% | n/a |
| Dong-A Socio 000640.KS | Pharmaceuticals: Major | $425M | -8% | -11% | +10% | 7% | 7.6× |
| SEERS 458870.KS | Medical Specialties | $409M | -44% | -70% | +425% | 43% | 10.1× |
| JW Pharmaceutical 001060.KS | Pharmaceuticals: Major | $402M | -18% | -28% | +10% | 14% | 6.2× |
| Hyundai Bioscience 048410.KS | Pharmaceuticals: Major | $401M | -23% | -58% | +78% | -580% | n/a |
| Onconic Therapeutics 476060.KS | Biotechnology | $391M | -25% | -45% | +179% | 21% | n/a |
| Rznomics 476830.KS | Biotechnology | $386M | -34% | -79% | -72% | -1,440% | n/a |
| InBody 041830.KS | Medical Specialties | $378M | -21% | +43% | +21% | 19% | 11.4× |
| G2GBIO 456160.KS | Biotechnology | $370M | -32% | -65% | -45% | -2,884% | n/a |
| Pharmicell 005690.KS | Pharmaceuticals: Major | $352M | -39% | -56% | +51% | 32% | 8.1× |
| BioNote 377740.KS | Medical Specialties | $343M | -2% | -10% | +13% | 16% | 15.0× |
| GC Corp. 005250.KS | Pharmaceuticals: Major | $319M | -5% | -32% | +10% | 1% | n/a |
| Medy-Tox 086900.KS | Biotechnology | $310M | -5% | -39% | +7% | 7% | 19.9× |
| Shinpoong Pharmaceutical 019170.KS | Pharmaceuticals: Major | $300M | -28% | -32% | +6% | 1% | n/a |
| i3system 214430.KS | Medical Specialties | $287M | -32% | -48% | +8% | 13% | n/a |
| i-SENS 099190.KS | Medical Specialties | $268M | -26% | -42% | +7% | 4% | 31.6× |